Figure 2
From: Utilizing MALDI-TOF MS and LC-MS/MS to access serum peptidome-based biomarkers in canine oral tumors
Peptide mass fingerprint of serum peptides from normal (CTRL), periodontitis (PD), benign tumors (BN), early-stage oral melanoma (EOM), late-stage OM (LOM) and late-stage oral squamous cell carcinoma (LOSCC) in the range 1500–2500 Da.
